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        Thymocyte diff  erentiation into the CD4 or 
CD8 lineages is a key event during the late 
steps of T cell development, in which precur-
sors that have rearranged TCR     and TCR     
genes and express both CD4 and CD8 (double 
positive [DP]) are selected into mature CD4 
T cells if MHC II–restricted, or CD8 T cells if 
MHC I–restricted (  Starr et al., 2003  ;   Bosselut, 
2004  ;   Singer and Bosselut, 2004  ). Lineage dif-
ferentiation is defi  ned by the onset of new pro-
grams of gene expression, most prominently 
the changes in   Cd4   and   Cd8   transcription from 
a DP to a single-positive (SP) CD4  +  CD8  –   or 
CD4  –  CD8  +   pattern. Several transcription fac-
tors selectively promote the diff  erentiation of 
either CD4 or CD8 T cells. The zinc fi  nger 
proteins Gata3 and Thpok (also called cKrox or 
Zbtb7b) are necessary for the generation of 
CD4 cells (  Hernández-Hoyos et al., 2003  ;   Pai 
et al., 2003  ;   He et al., 2005  ;   Sun et al., 2005  ), 
whereas the transcription factor Runx3 is im-
portant for CD8 T cell development, notably 
by promoting the cessation of   Cd4   expression 
(  Taniuchi et al., 2002a  ;   Ehlers et al., 2003  ; 
  Woolf et al., 2003  ;   Egawa et al., 2007  ). This 
function of Runx3 relies on the recruitment of 
Runx3 molecules to a cis-regulatory silencer 
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  The transcription factor Ets1 contributes to the differentiation of CD8 lineage cells in the 
thymus, but how it does so is not understood. In this study, we demonstrate that Ets1 is 
required for the proper termination of CD4 expression during the differentiation of major 
histocompatability class 1 (MHC I)–restricted thymocytes, but not for other events associ-
ated with their positive selection, including the initiation of cytotoxic gene expression, 
corticomedullary migration, or thymus exit. We further show that Ets1 promotes expression 
of Runx3, a transcription factor important for CD8 T cell differentiation and the cessation 
of   Cd4   gene expression. Enforced Runx3 expression in Ets1-defi  cient MHC I–restricted 
thymocytes largely rescued their impaired   Cd4   silencing, indicating that Ets1 is not re-
quired for Runx3 function. Finally, we document that Ets1 binds at least two evolutionarily 
conserved regions within the   Runx3   gene in vivo, supporting the possibility that Ets1 
directly contributes to   Runx3   transcription. These fi  ndings identify Ets1 as a key player 
during CD8 lineage differentiation and indicate that it acts, at least in part, by promoting 
  Runx3   expression. 
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comprises CD4 or CD8 SP cells that have successfully com-
pleted positive selection and escaped negative selection 
(  Fowlkes and Pardoll, 1989  ;   Kishimoto and Sprent, 1999  ). In 
  Ets1        /      mice, this subset included an unusual contingent of 
CD4  +  CD8  +   thymocytes (  Fig. 1, B and C  ). Such maturelike 
TCR  hi   CD24  lo   DP thymocytes were present in the thymus of 
Ets1-defi  cient newborn mice, indicating that this subset did 
not result from the accumulation over time of small numbers 
of long-lived thymocytes (  Fig. S1  ). There was no maturelike 
DP subset in   Ets1    +/      thymi, which were phenotypically simi-
lar to their   Ets1    +/+   counterparts     (unpublished data) and were 
used as controls in some experiments. 
  We next evaluated if this unusual maturelike DP popula-
tion resulted from MHC I– or MHC II–induced positive se-
lection by generating   Ets1        /      mice carrying defi  ned TCR 
specifi   cities. In mice carrying the MHC I–restricted P14 
TCR, which recognizes an LCMV-derived peptide presented 
by K  b  , thymocytes being positively selected express high levels 
of the transgenic V    2 and V    8 TCR chains (  Pircher et al., 
1989  ). The frequency of V    8  +   thymocytes was lower in  Ets1        /      
than in   Ets1    +/+   P14 mice (  Fig. S2 A  ), presumably refl  ecting 
the role of Ets1 in early thymocyte development and notably 
its requirement for effi   cient TCR     allelic exclusion (  Eyquem 
et al., 2004  ). Nonetheless, the correlation between V    8 and 
V    2 expression was excellent in both genotypes, and we used 
either marker to characterize P14 thymocytes undergoing se-
lection. Postselection V    2  hi   CD24  lo   thymocytes were present 
in   Ets1    +/+   and   Ets1        /      P14 mice in similar numbers (  Fig. 2, 
A [middle] and B  ), and   Ets1   disruption did not prevent the up-
regulation of CD69, a surface molecule normally expressed in 
response to TCR signaling (  Swat et al., 1993  ; Fig. S2 B); thus, 
Ets1 was not required for thymocytes to respond to positively 
selecting TCR engagements.   However, postselection V    2  hi   
CD24  lo     Ets1        /      thymocytes were mostly CD4  +  CD8  +  , unlike 
their   Ets1    +/+   counterparts, which were predominantly CD4  –
  CD8  +   (  Fig. 2, A [right] and B  ). Thus, MHC I–induced posi-
tive selection in the absence of Ets1 results in the generation 
of maturelike DP thymocytes. Correspondingly, the frequency 
and number of CD8 SP thymocytes were substantially re-
duced in   Ets1        /      P14 TCR mice relative to their   Ets1    +/+   
counterparts (  Fig. 2, A [left] and B  ). 
  In contrast with these fi  ndings, positive selection by the MHC 
II-restricted OT-II TCR, which recognizes an ovalbumin-
derived peptide presented by I-A  b   (  Hogquist et al., 1994  ), did 
not result in the presence of a maturelike DP population on 
the   Ets1        /      background, and instead gave rise to a CD4-
skewing of mature thymocytes similar to that on the   Ets1    +/+   
background (Fig. S2 C). 
    Ets1      /        maturelike DP thymocytes are localized 
in the thymic medulla 
  It was important to assess other indicators of diff  erentiation in 
  Ets1        /      DP TCR  hi   CD24  lo   thymocytes, notably to verify 
that the presence of this subset was not simply refl  ecting a re-
quirement for Ets1 for CD24 expression. Normally, preselec-
tion TCR  lo   DP thymocytes reside in the thymic cortex, 
element located in the fi  rst intron of the   Cd4   gene (  Taniuchi 
et al., 2002a  ,   2004  ).   Runx3   has been shown to be up-regu-
lated during the diff  erentiation of DP thymocytes into CD8 
cells in the thymus (  Sato et al., 2005  ;   Egawa et al., 2007  ; 
  Egawa and Littman, 2008  ), but little is known about the tran-
scriptional circuitry that controls its transcription. 
  Ets1 is the prototype of a family of transcription factors 
that bind specifi  c DNA sequences typically centered over a 
GGAA tetranucleotide motif (  Sharrocks, 2001  ;   Verger and 
Duterque-Coquillaud, 2002  ). Multiple Ets factors are ex-
pressed in DP and SP thymocytes, including Ets1 and the re-
lated protein Ets2, both present throughout T cell development 
without marked preference for any T cell subset (  Anderson 
et al., 1999  ). Despite this potential for functional redundancy, 
mice lacking Ets1 have impaired development of NK and 
T cells (  Barton et al., 1998  ;   Eyquem et al., 2004  ), and Ets1 is 
essential for Th1 eff  ector diff  erentiation (  Grenningloh et al., 
2005  ). Ets1 participates in two important aspects of early thy-
mocyte development, allelic exclusion during TCR     gene 
rearrangement and the survival of early (pre-DP) thymocytes 
(  Eyquem et al., 2004  ). Although   Ets1        /      mice have reduced 
thymocyte numbers as a result of these early eff  ects, initial 
studies did not report major anomalies of late thymocyte 
development (  Bories et al., 1995  ;   Muthusamy et al., 1995  ; 
  Barton et al., 1998  ). However, it was noticed that   Ets1        /      CD8 
SP cells maintained low-level CD4 expression (  Barton et al., 
1998  ), a fi  nding confi  rmed by a more recent study that showed 
that this defect is cell autonomous (  Clements et al., 2006  ). How 
Ets1 aff  ects CD8 lineage diff  erentiation has remained poorly 
understood. Because Ets1 was reported not to aff  ect expres-
sion of   Runx3  , it was proposed that   Ets1   disruption aff  ected 
Runx3-mediated   Cd4   silencing (  Clements et al., 2006  ). 
  In this study, we have examined how Ets1 contributes to 
CD8 T cell diff  erentiation. We show that Ets1 promotes the 
proper cessation of CD4 expression during the diff  erentiation 
of MHC I–restricted thymocytes. However, Ets1 is not re-
quired for Runx3-mediated   Cd4   silencing. Rather, Ets1 is 
important for   Runx3   expression in these cells and binds at 
least two regions of the   Runx3   gene. Our fi  ndings identify 
Ets1 as an important regulator of Runx3 expression and estab-
lish a novel connection in the network of transcription factors 
that control CD8 T cell diff  erentiation in the thymus. 
  RESULTS 
    Ets1      /        mice contain an MHC I–restricted “maturelike” 
DP thymocyte population 
  Consistent with previous studies (  Barton et al., 1998  ; 
  Eyquem et al., 2004  ;   Clements et al., 2006  ),   Ets1        /      thymi 
were hypocellular (40–50% of wild-type littermates;   Table S1  ). 
Flow cytometric analyses of CD4 and CD8 expression showed 
a reduced frequency of CD8 SP thymocytes contrasting 
with a normal or increased representation of CD4 SP cells 
(  Fig. 1 A  ).   Given the low cellularity of   Ets1        /      thymi, this 
resulted in substantially reduced numbers of CD8 SP thymo-
cytes (25–30% of wild-type controls; Table S1). The most 
mature thymocyte subset, defi  ned as TCR  hi   CD24  lo  , normally JEM VOL. 206, November 23, 2009 
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  Klug et al., 1998  ). These experiments were performed on 
mice carrying the P14 TCR transgene in which thymocyte 
diff  erentiation is normally skewed toward the CD8 lineage. 
K14  +   medullary areas in P14   Ets1    +/+   thymi contained mostly 
CD8 SP and only a few CD4 SP cells, whereas the K14-
negative cortical areas were occupied by DP thymocytes (  Fig. 3 B  , 
top). K14-positive medullary areas were clearly defi  ned in 
P14   Ets1        /      thymi; however, they were packed with DP 
thymocytes (  Fig. 3 B  , bottom) and could not be distinguished 
from the surrounding cortex on the basis of CD4 and CD8 
expression alone, unlike the clear boundary seen in the P14 
whereas positively selected thymocytes migrate to the me-
dulla, as a result of their up-regulating the chemokine recep-
tor CCR7 (  Takahama, 2006  ). Flow cytometry analyses 
showed that   Ets1        /      TCR      hi   DP thymocytes were uni-
formly CCR7  hi  , expressing CCR7 levels similar to those 
seen in   Ets1    +/+   SP thymocytes and >10 times higher than 
those on TCR  lo   DP cells (either   Ets1    +/+   or   Ets1        /     ;   Fig. 3 A  ).   
To evaluate if these CCR7  hi   DP thymocytes migrated to 
the medulla, we compared thymus sections of   Ets1        /      and 
  Ets1    +/+   mice by immunohistological analysis of CD4 and 
CD8, and of the medullary cell marker cytokeratin 14 (K14; 
    Figure 1.     Mature thymocytes fail to resolve into CD4 and CD8 SP populations in   Ets1  -defi  cient mice.   (A and B) Thymocytes from   Ets1  +/+   (top) 
or   Ets1     /     (bottom) mice were assessed by fl  ow cytometry for surface expression of CD4, CD8, CD24, and TCR    . Two-parameter contour plots are shown 
on all live cells for expression of CD4 and CD8 (A) or of CD24 and TCR     (B, left); TCR  hi   CD24 lo   mature thymocytes are analyzed for CD4 and CD8 expres-
sion (B, right). Numbers next to boxes indicate the percentage of cells within that box. Note that the level of CD24 expression was not affected by   Ets1  
disruption by itself. Data are from more than three experiments. (C) Bar graphs (mean ± SEM;   n   = 5 for each genotype) represent the absolute numbers of 
thymocytes within each mature (TCR    hi   CD24 lo )  subset.   2688 Ets1 and CD8 lineage differentiation   | Zamisch et al. 
I–restricted DP thymocytes were cells that undergo CD8 dif-
ferentiation and fail to silence CD4, or cells that are redi-
rected to the CD4 lineage and fail to silence CD8. We 
submitted maturelike   Ets1        /      P14 DP thymocytes to real-
time RT-PCR analysis of mRNAs encoding the transcrip-
tion factor Thpok and the cytotoxic marker perforin, 
normally expressed in CD4 and CD8 lineage thymocytes, 
  Ets1    +/+   thymus. We conclude from these analyses that   Ets1        /      
maturelike DP thymocytes have the same medullary location 
as wild-type SP thymocytes. 
    Ets1      /        maturelike DP thymocytes are CD8 lineage cells 
  Because MHC I–induced selection normally gives rise to 
CD8-linage cells, we examined if   Ets1        /      maturelike MHC 
    Figure 2.       Ets1        /      MHC I–restricted thymocytes fail to down-regulate CD4 during the late stages of positive selection.   (A) Thymocytes from 
  Ets1  +/+   (top) or   Ets1     /     (bottom) mice carrying the P14 TCR transgene were assessed for expression of CD4, CD8, CD24, and the transgenic V   2  TCR   
chain. Two-parameter contour plots of CD4 and CD8 expression (left) show a reduced frequency of CD8 SP cells in   Ets1     /     thymi. The V   2 hi   CD24 lo   subset 
is defi  ned on two-parameter contour plots of CD24 and V    2 expression (middle), and analyzed for CD4 and CD8 expression (right). Data are from more 
than three experiments. (B) Bar graphs (mean ± SEM) represent the absolute numbers of thymocytes within each mature (V   2 hi   CD24 lo  ) subset. Total thy-
mocyte numbers (average ± SEM; × 10     6 ;   n   = 7) were 111 ± 23 and 43 ± 4.8 in   Ets1  +/+   and   Ets1     /     P14  mice,  respectively.   JEM VOL. 206, November 23, 2009 
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ous studies had documented that surface reexpression of core-
ceptor molecules in this assay is indicative of   Cd4   and   Cd8   gene 
expression (  Brugnera et al., 2000  ;   Yu et al., 2003  ). Most mature-
like (V   2  hi   CD24  lo  ) DP thymocytes from P14 transgenic  Ets1        /      
mice reexpressed both CD4 and CD8 after pronase stripping, 
unlike their CD8 SP counterparts that only reexpressed CD8 
(  Fig. 5 A  , bottom and top rows).   However, CD4 reexpression 
levels were lower on maturelike DP than on their immature 
V    2  hi   CD24  hi   counterparts (  Fig. 5 A  , bottom and middle rows). 
We draw two conclusions from these experiments. First, ma-
turelike DP thymocytes actively express   Cd4  , indicating im-
paired silencing. Second, the lower CD4 reexpression by that 
population, compared with its CD24  hi   counterparts, suggest that 
some maturelike DP cells may eventually silence   Cd4   and 
respectively (  Fig. 4  , rightmost two columns).   As expected, 
  Ets1        /      CD8 SP thymocytes expressed perforin but no 
Thpok (  Fig. 4  , second column). Importantly, the same was 
true of maturelike DP thymocytes (V    2  hi   CD24  lo   DP cells 
from   Ets1        /      P14 transgenic mice;   Fig. 4  , left column), indi-
cating that these cells had a gene expression pattern typical of 
CD8 lineage cells. 
  We considered the possibility that maturelike DP thymo-
cytes might be in the process of silencing   Cd4  , so that their ex-
pression of surface CD4 molecules would not be indicative of 
active   Cd4   gene expression. To address this possibility, we mea-
sured CD4 and CD8 protein reexpression in sorted   Ets1        /      P14 
thymocytes that had been “stripped” of their surface coreceptor 
proteins by mild pronase digestion (  Suzuki et al., 1995  ). Previ-
    Figure 3.       Ets1        /      MHC I–restricted maturelike DP thymocytes migrate to the medulla.   (A) Thymocytes from   Ets1  +/+   and   Ets1     /     mice  were 
stained for surface expression of CD4, CD8, TCR     and the chemokine receptor CCR7. Overlaid histograms (right plots) analyze expression of CCR7 on 
  Ets1     /     DP and CD4 SP thymocytes (bottom graph), and on   Ets1  +/+   CD8 and CD4 SP thymocytes (top graph), all TCR    hi   (as gated in left plots). Expression 
of CCR7 on TCR  lo   DP thymocytes is shown in both strains as a negative control (dark gray histograms). Data are representative of two experiments. 
(B) Frozen thymic sections were prepared from P14 transgenic   Ets1  +/+   or   Ets1     /     mice, stained for cytokeratin 14 (K14, pseudo-colored as blue, defi  ning 
medullary areas), CD4 (red), and CD8 (green). Overlaying CD4 and CD8 staining (right) shows exclusion of DP cells from medullary areas in   Ets1  +/+   but  not 
in   Ets1     /     mice. The red medullary staining in   Ets1  +/+   mice is contributed by the few CD4 SP cells that develop in these recombination-competent ani-
mals. Bars, 100 μm. Data are representative of three experiments.     2690 Ets1 and CD8 lineage differentiation   | Zamisch et al. 
there is little or no   Runx3   gene expression in preselection DP 
thymocytes, and its preferential up-regulation during the DP to 
CD8 SP transition results in higher mRNA levels in CD8 than 
in CD4 SP thymocytes (  Taniuchi et al., 2002a  ;   Liu and Bosselut, 
2004  ;   Egawa et al., 2007  ). Analyses of   Runx3   expression in ma-
turelike DP thymocytes selected by endogenously rearranged 
TCRs are hampered by the small numbers of these cells; an ad-
ditional level of complexity comes from alternative promoter 
usage in the   Runx3   gene, resulting in mRNA species that appear 
to not equally contribute to Runx3 protein synthesis (  Egawa 
et al., 2007  ;   Egawa and Littman, 2008  ). To overcome these ob-
stacles, we introduced into   Ets1        /      mice a transgenic BAC re-
porter in which the sequence coding for the tandem-dimer-tomato 
red fl  uorescent protein (tRFP ;   Shaner et al., 2005  ) had been in-
serted into the second exon of the   Runx3   gene (  Fig. S4 A   and 
unpublished data). As the tRFP cDNA insertion respects all 
  Runx3   noncoding sequences, and as tRFP translation is initiated 
from endogenous   Runx3   ATG codons, expression of tRFP in 
the thymus matched expression of endogenous Runx3 protein 
(  Woolf et al., 2003  ;   Egawa et al., 2007  ). In wild-type thymi, we 
readily detected tRFP in a subset of DN cells and in CD8 lin-
eage thymocytes, whereas little or no expression was seen in DP 
and CD4 lineage cells (Fig. S4 B and unpublished data). Simi-
larly, there was little tRFP fl  uorescence in   Ets1        /      CD4 lineage 
cells. However, fl  uorescence intensities in CD8 SP thymocytes 
were slightly lower in   Ets1        /      than in their wild-type counter-
parts and tRFP expression in maturelike DP thymocytes was 
half of that in wild-type CD8 SP thymocytes (  Fig. 6 A  ).   In fact, 
the fraction of positively selected (TCR  hi  ) thymocytes that ex-
pressed   Runx3  , as well as their level of expression, were lower in 
Ets1-defi  cient than Ets1-suffi   cient thymocytes, indicating that 
the low expression observed on maturelike DP cells did not re-
sult from a gating bias (  Fig. 6 B  ). These experiments indicated 
that Ets1 is important for appropriate   Runx3   expression. 
  We verifi  ed that reduced expression of the   Runx3   re-
porter was indicative of reduced endogenous Runx3 expres-
sion using mice carrying the P14 TCR transgene.   Runx3   
mRNA expression was lower in   Ets1        /      maturelike DP than 
in CD8 SP cells, whether wild-type or   Ets1        /      (  Fig. 6 C  ), 
and the same was true of Runx3 protein expression (  Fig. 6 D  ), 
demonstrating that   Ets1   disruption results in defective Runx3 
up-regulation during the positive selection of MHC I–
restricted thymocytes. This defect was specifi  c to Runx3, as 
expression of Runx1 remained unchanged in all three subsets 
in   Ets1        /      mice (  Fig. 6 D  ). Consistent with analyses of Runx3 
reporter mice, Ets1 was not strictly required for Runx3 up-
regulation; in   Ets1        /      mice Runx3 was detectable (although 
low) in maturelike DP thymocytes and present at subnormal 
levels in CD8 SP cells (  Fig. 6, C and D  ). Thus, although Ets1 
is not required for Runx3 expression, it is necessary for its 
proper up-regulation during CD8 lineage diff  erentiation. 
  Enforced Runx3 expression restores CD4 silencing 
in   Ets1      /        thymocytes 
  Having shown that Ets1 promotes   Runx3   expression during 
CD8 cell diff  erentiation, we next investigated if Ets1 was 
convert to a CD8 SP phenotype. However, the presence of DP 
T cells in the spleen of adult and neonate   Ets1        /      mice (  Fig. 5 B   
and not depicted) suggests that at least some maturelike DP thy-
mocytes complete their intrathymic development before termi-
nating   Cd4   expression. 
  Ets1 promotes Runx3 expression 
  We concluded from the previous fi  ndings that   Ets1   disruption 
impaired the cessation of   Cd4   expression during CD8 diff  eren-
tiation. The lineage specifi  city of   Cd4   expression is determined 
by the   Cd4   silencer, a 434-bp element located in the fi  rst intron 
of the   Cd4   gene (  Taniuchi et al., 2004  ). The silencer is activated 
in CD8-diff  erentiating thymocytes, a process that normally re-
quires the recruitment of the transcription factor Runx3, whose 
expression is up-regulated during CD8 diff  erentiation (  Taniuchi 
et al., 2002a  ;   Woolf et al., 2003  ;   Grueter et al., 2005  ). Thus, the 
impaired   Cd4   silencing in   Ets1        /      thymocytes indicated that 
Ets1 is important for the expression of Runx3 molecules, for 
their ability to repress   Cd4   expression, or for both. 
  To distinguish between these possibilities, we fi  rst examined 
  Runx3   expression in   Ets1        /      thymocytes. In wild-type mice, 
    Figure 4.       Ets1        /      MHC I–restricted maturelike DP thymocytes are 
CD8 lineage cells.   Expression of the genes encoding Thpok (  Zbtb7b )  and 
perforin (  Prf1  ) was analyzed by real-time RT-PCR on sorted V   2 hi   CD24 lo  
CD4  + CD8 +   and CD4  – CD8 +   thymocyte populations from   Ets1  +/+   and 
  Ets1     /     mice carrying the P14 TCR transgene (left three columns) and on 
TCR  hi   CD4 + CD8 –   thymocytes from wild-type mice (right column). mRNA 
levels, normalized on     -actin expression in the same sample, are shown 
relative to those in wild-type CD4  + CD8 –   cells (Thpok) or   Ets1  +/+   P14  CD4     
CD8  +   cells (Prf1). Bars indicate the mean values derived from triplicate 
determination from a single sorted population; error bars show standard 
deviations. Data are representative of three or more independent sorted 
samples for each population.     JEM VOL. 206, November 23, 2009 
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    Figure 5.     Persistent CD4 expression in   Ets1        /      maturelike DP thymocytes.   (A) Thymocytes subsets from P14 TCR   Ets1     /     mice were sorted as indi-
cated in   Fig. S3  , stripped of their surface coreceptor molecules, and analyzed by fl  ow cytometry for CD4 and CD8 surface expression after overnight 
single-cell suspension culture (right column). An aliquot of the pronase-treated cells was kept at 4°C and analyzed in parallel to verify the complete removal 
of CD4 and CD8 surface molecules after pronase digestion (third column). No change in surface coreceptor expression was seen in the absence of pro-
nase treatment (two left columns). Data are representative of two separate experiments. Numbers in graphs indicate the mean fl  uorescence intensity of 
CD4 staining on CD8  +   cells. (B) Splenocytes were prepared from 1-wk-old   Ets1  +/+   and   Ets1     /     mice and analyzed as in   Fig. 1   for expression of CD4, CD8, 
and TCR    . CD4 versus CD8 two-parameter contour plots derived from TCR  hi   splenocytes show CD4  + CD8 +   splenocytes in   Ets1     /     mice. Data are represen-
tative of six   Ets1     /     and three   Ets1  +/+   neonates analyzed in two separate experiments.     2692 Ets1 and CD8 lineage differentiation   | Zamisch et al. 
    Figure 6.       Ets1   promotes   Runx3   expression.   (A and B) Expression of   Runx3   was evaluated in mice carrying a BAC transgene in which a tRFP cDNA 
has been inserted within the second exon of   Runx3  . (A) Two-parameter contour plots of CD4 and CD8 expression (top) are gated on TCR  hi   CD24 lo   thymo-
cytes from   Ets1  +/      and   Ets1     /     mice. Subsets defi  ned by boxes are numbered and analyzed for tRFP expression. Overlaid histograms (bottom) depict tRFP 
fl  uorescence in indicated subsets of tRFP-transgenic   Ets1  +/      and   Ets1     /     mice. Gray-shaded histogram show background fl  uorescence in CD8 SP thymo-
cytes from control   Ets1  +/+   nontransgenic mice. The mean intensity of tRFP fl  uorescence in subset 1 (maturelike DP cells from   Ets1     /     mice) was 49% of 
that in subset 4 (CD8 SP cells from tRFP-transgenic   Ets1  +/      controls; mean on all three experiments). (B) Two parameter plots of tRFP and CD24 expres-
sion (bottom) are shown on TCR  hi   gated cells (histograms, top). Data (A and B) is representative of three mice of each genotype analyzed in three separate JEM VOL. 206, November 23, 2009 
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et al., 2005  ). Anti-Ets1 ChIP did not detect any specifi  c Ets1 
binding when performed on P14 TCR transgenic thymocytes 
(unpublished data), possibly because of the low representation 
of CD8-diff  erentiating thymocytes, even in P14 transgenic 
mice, or of an insuffi   cient Ets1 protein contents in thymo-
cytes. To overcome these limitations, we considered that, be-
cause both Ets1 and Runx3 are expressed in Th1-diff  erentiating 
eff  ectors  (  Grenningloh et al., 2005  ;   Djuretic et al., 2007  ; 
  Naoe et al., 2007  ), it was possible that Ets1 was also important 
for   Runx3   expression in these cells. To evaluate this possibility, 
we assessed Th1 eff  ectors carrying the   Runx3  -tRFP reporter. 
As expected, tRFP was expressed at greater levels in Th1 than 
in Th2 eff   ectors (unpublished data); tRFP expression was 
lower in Ets1-defi  cient than in Ets1-suffi   cient Th1 eff  ectors, 
indicating that Ets1 activation of   Runx3   expression is not lim-
ited to CD8-diff  erentiating thymocytes (  Fig. 8 A  ).   
  In light of these results, we examined if we could detect 
Ets1 binding to the   Runx3   promoter in Th1 eff  ector cells. In-
deed, ChIP assays demonstrated specifi  c binding within a re-
gion surrounding the distal promoter, that is specifi  cally active 
in CD8 lineage cells (  Egawa et al., 2007  ;   Egawa and Littman, 
2008  ; amplifi  ed segments D and E;   Fig. 8 B   and   Fig. S8 A  ). 
This evolutionary conserved region includes GGAA motifs 
compatible with Ets binding (Fig. S8 B). The enrichment of 
these segments in anti-Ets1 immunoprecipitates was two to 
three times greater than that of two irrelevant segments from the 
ROR     and TLR9 genes that we used as specifi  city controls 
(  Fig. 8 B  ). Further supporting the conclusion that the binding 
around segments D and E was specifi  c, little or no binding was 
detected to a region upstream of the promoter (amplifi  ed seg-
ment C;   Fig. 8 B   and Fig. S8, A and B). A search for additional 
conserved Ets motifs revealed potential binding sites in a re-
gion within the second   Runx3   intron. Indeed, ChIP assays 
found strong Ets1 binding to a region (amplifi  ed segment G; 
  Fig. 8 B   and Fig. S8, A and C) containing a highly conserved 
AGGAAGY sequence that matches the consensus for Ets1 
DNA binding (  Sharrocks, 2001  ;   Verger and Duterque-
Coquillaud, 2002  ). We conclude from these experiments that 
Ets1 is recruited to multiple sites within the   Runx3   locus in 
Th1 eff  ectors; these fi  ndings support the possibility that Ets1 
acts as a direct activator of   Runx3   expression. 
  In summary, the present study demonstrates ChIP bind-
ing of Ets1 on   Runx3  , Ets1-dependence of   Runx3   expression 
in two distinct cell types, and developmental rescue of Ets1 
defi  ciency by Runx3 expression, and leads us to conclude 
required for Runx3 to repress   Cd4  . To evaluate this possibil-
ity, we introduced into   Ets1        /      mice a   Runx3   transgene ex-
pressed throughout T cell development, starting at or before 
the preselection DP stage (  Grueter et al., 2005  ). We reasoned 
that this transgene would fail to restore CD4 silencing in 
  Ets1        /      mice if silencer activation by Runx3 molecules re-
quired Ets1 expression. Unlike in wild-type mice, and as pre-
viously shown (  Grueter et al., 2005  ), Runx3 was expressed at 
all post-DN stages in the transgenic mice, including preselec-
tion DP thymocytes (CD69        cells) and CD4 lineage cells 
(  Fig. S5 A  ). On a per-cell basis, expression of Runx3 mole-
cules in transgenic CD69  –   cells was not greater than that of 
endogenous Runx3 in wild-type CD8 lineage cells, indicat-
ing that the transgene did not result in Runx3 overexpression 
(  Grueter et al., 2005  ; Fig. S5 A). Furthermore, expression of 
the transgene was not aff  ected by   Ets1   disruption (  Fig. S6  ). 
  We introduced the   Runx3   transgene into Ets1-suffi   cient 
and -defi  cient P14 TCR transgenic mice, and assessed the 
V    8  hi   (or V    2  hi  ) CD24  lo   subset for expression of CD4 and 
CD8. Expression of the   Runx3   transgene on the P14   Ets1        /      
background resulted in a substantial reduction in the size of the 
maturelike DP subset (  Fig. 7 A, right  ), with     80% of the 
V    8  hi   CD24  lo   cells having down-regulated CD4 (  Fig. 7 B  ).   
Transgenic Runx3 expression had previously been shown to 
cause CD4 down-regulation in preselection thymocytes ( Telfer 
et al., 2004  ;   Grueter et al., 2005  ;   Kohu et al., 2005  ;   Wildt 
et al., 2007  ), and analyses gated on all live cells showed that this 
was the case in Ets1-defi  cient thymocytes as well (  Fig. S7  ). Be-
cause expression of transgenic Runx3 on a per-cell basis did 
not exceed that of endogenous Runx3 (Fig. S5 A), we inter-
pret the early repression of   Cd4   as refl  ecting the premature 
expression of transgenic compared with endogenous Runx3 
rather than being caused by Runx3 overexpression. We con-
clude from these experiments that Runx3-mediated   Cd4   si-
lencing does not require Ets1, and that the impaired   Cd4   
silencing observed in   Ets1        /      CD8 lineage cells is caused at least 
in part by their impaired Runx3 expression. 
  In vivo recruitment of Ets1 to the Runx3 gene 
  These fi  ndings prompted us to examine if Ets1 could directly 
promote   Runx3   transcription by binding to specifi  c sites 
within the   Runx3   gene. To evaluate this possibility, we per-
formed chromatin immunoprecipitation (ChIP) assays with 
an anti-Ets1 antibody that detects Ets1 binding to the IFN-     
promoter in Th1-diff  erentiating eff  ector T cells (  Grenningloh 
experiments. (C) Expression of   Runx3   was assessed as in   Fig. 4   on the same mRNA preparations and is shown relative to that in   Ets1  +/+   P14  CD4 – CD8 +  
cells. The difference between   Ets1     /     V  2 hi   CD24 lo   DP and   Ets1  +/+   CD8 SP thymocytes for   Runx3   expression was statistically signifi  cant (*, P < 10     4 ,  two 
tailed Student’s   t   test). Data are from more than three experiments. (D) Expression of Runx proteins was assessed in sorted thymocyte subsets by immuno-
blotting with an antibody directed against the Runt domain and recognizing both Runx1 and Runx3. CD4 SP thymocytes were sorted from wild-type 
mice and used as positive and negative controls for Runx1 and Runx3 expression, respectively. MW marker sizes are indicated on the left. Numbers un-
derneath indicate expression of     -actin in each samples, quantifi  ed on the same membrane and expressed relative to that of wild-type CD8 SP thymo-
cyte. The     -actin signal was consistently lower in DP thymocytes than in other cell subsets, but was not reproducibly affected by   Ets1   disruption.  The 
fi  gure is a composite of two parts of a single blot (separated as indicated by the vertical black bar). Data are from three determinations performed from 
two distinct sets of sorted cells.     
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from the observation that the transcription factor Ets1 is re-
quired for the proper repression of CD4 during CD8 lineage 
diff  erentiation. We show that   Ets1   disruption impairs expres-
sion of   Runx3   and we provide evidence that Ets1 directly 
contributes to   Runx3   transcription. These fi  ndings identify 
Ets1 as a new node in the transcriptional circuitry that or-
chestrates CD4-CD8 diff  erentiation (  Wang and Bosselut, 
2009  ). Although these fi  ndings contrast with the opposite 
conclusion reached by a previous work (  Clements et al., 2006  ), 
that study evaluated   Runx3   expression on unfractionated 
DP thymocytes expressing a diverse TCR repertoire. Both in 
wild-type and   Ets1        /      mice, unfractionated DP thymocytes 
mostly comprise preselection cells that express little or no   Runx3  , 
presumably making that approach not sensitive enough to 
that Ets1 promotes   Cd4   silencing during CD8 lineage diff  er-
entiation at least in part by promoting Runx3 expression. 
  DISCUSSION 
  The activation of   Runx3   expression is a critical event during 
the diff  erentiation of CD8 T cells from DP thymocytes, and 
signals the onset of   Cd4   down-regulation (  Egawa and Littman, 
2008  ). However, the control of   Runx3   expression in the 
thymus has remained largely mysterious. Although the CD4-
diff  erentiating factor Thpok represses   Runx3   (  Egawa and 
Littman, 2008  ;   Muroi et al., 2008  ;   Wang et al., 2008b  ), it is 
not yet known whether this eff  ect is direct, and no factor has 
been shown to promote   Runx3   expression in CD8-diff  eren-
tiating thymocytes. This study addressed this issue starting 
    Figure 7.     Enforced Runx3 expression restores CD4 down-regulation in   Ets1        /      MHC I–restricted thymocytes.   (A) Thymocytes were prepared 
from   Ets1  +/      and   Ets1     /     mice, carrying either the P14 TCR transgene only or both the P14 and   Runx3   transgenes, and stained for CD4, CD8, CD24 and 
V    8. Two-parameter contour plots show CD4 and CD8 expression on gated V   8 hi   CD24 lo   thymocytes. (B) Bar graph indicates the percentages (average ± 
SEM; n: number of mice of each genotype) of V   2 hi   or  V  8 hi   CD24 lo   DP and CD8 SP thymocytes in each strain (all carrying the P14 TCR transgene). In 
these experiments, Ets1-competent control mice (  Ets1  +  ) were either   Ets1  +/      or   Ets1  +/+  ; both genotypes resulted in similar Ets1-suffi  cient phenotypes. Data 
in (A) and (B) is from more than three experiments.     JEM VOL. 206, November 23, 2009 
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assess   Runx3   gene expression in the relevant CD24  lo   TCR  hi   
thymocyte population. 
  Deciphering the roles of Runx proteins in positive selec-
tion and lineage diff  erentiation has been complicated by the 
functional redundancy between the two   Runx   genes expressed 
in developing T cells,   Runx1   and   Runx3   (  Taniuchi et al., 
2002a  ;   Woolf et al., 2003  ;   Egawa et al., 2007  ). Disruption of 
both genes in DP thymocytes prevents CD8 cell diff  erentiation 
(  Egawa et al., 2007  ). In post-DN thymocytes, expression of 
  Runx1   is somewhat promiscuous, whereas expression of   Runx3   
is largely restricted to CD8-diff  erentiating cells, suggesting that 
Runx3 is the main component of the Runx activity that pro-
motes CD8 diff  erentiation. Indeed,   Runx1   inactivation does 
not aff  ect CD4 expression during CD8 cell diff  erentiation 
(  Taniuchi et al., 2002a  ;   Woolf et al., 2003  ;   Egawa et al., 2007  ). 
However, the sole disruption of   Runx3   impairs CD8 lineage 
diff  erentiation only partially, and notably results in incomplete 
  Cd4   derepression in CD8 lineage thymocytes (  Taniuchi et al., 
2002a  ;   Woolf et al., 2003  ;   Egawa et al., 2007  ). Disruption of 
  Runx3   also results in increased Runx1 protein expression in 
CD8 lineage cells (  Egawa and Littman, 2008  ), which is instru-
mental in attenuating the consequences of   Runx3   disruption. 
Indeed, hemizygous inactivation of   Runx1   in   Runx3  -defi  cient 
thymocytes completely abrogates   Cd4   silencing by CD8 cells 
(  Woolf et al., 2003  ), a result that is in line with other observa-
tions underscoring the sensitivity of Runx function to gene 
dosage (  Barton and Nucifora, 2000  ). 
  Indirect comparisons with published studies (  Taniuchi 
et al., 2002a  ;   Woolf et al., 2003  ;   Egawa et al., 2007  ) suggest 
that the loss of   Cd4   silencing is greater in Ets1- than in 
Runx3-defi  cient CD8 lineage thymocytes, despite the resid-
ual Runx3 expression in the former. We see three potential 
explanations to this apparent paradox. First, unlike disruption 
of   Runx3  , disruption of   Ets1   did not result in compensatory 
Runx1 up-regulation, consistent with a more pronounced 
eff  ect on   Cd4   silencing. Second, it is possible that Ets1 aff  ects 
the expression of additional factors involved in   Cd4   silencer 
function. Notably, two silencer DNA motifs, presumably re-
cruiting thus far unknown factors, are required for   Cd4   re-
pression during CD8 lineage diff  erentiation (  Taniuchi et al., 
2002b  ). It is conceivable that Ets1 is important for the ex-
pression of such additional silencer-binding proteins, thereby 
controling multiple key players of CD8 lineage diff  erentia-
tion. If that is the case, the rescue of   Cd4   repression in   Ets1        /      
cells by Runx3 could indicate partial redundancy between 
such factors and Runx3. Alternatively, it is possible that the 
expression of these unknown silencer-binding factors is itself 
under the control of Runx3. In line with this possibility, 
Runx3 uses such a “feed-forward” loop to promote cyto-
toxic gene expression in eff  ector CD8 T cells (  Cruz-Guilloty 
et al., 2009  ). 
  Third, it has been proposed that Ets1 could bind the si-
lencer and directly cooperate with Runx3 to repress   Cd4   ex-
pression (  Clements et al., 2006  ), in line with the in vitro 
synergy between Ets1 and Runx1 for TCR and BCR en-
hancer activation (  Kim et al., 1999  ;   Erman et al., 1998  ;   Goetz 
    Figure 8.     Ets1 binds the   Runx3   locus.   (A) Ets1 promotes   Runx3   ex-
pression in Th1-differentiating CD4 effectors. Bead-purifi  ed CD4  + CD8 –   LN 
T cells from tRFP transgenic   Ets1     /     or   Ets1  +/      mice were activated under 
Th1 conditions and analyzed for tRFP expression 5 d later. Overlaid histo-
gram show tRFP expression in gated CD4  + CD8 –    Ets1     /     (plain line) and 
  Ets1  +/      (dashed line) effector cells. The gray-shaded histogram shows 
background fl  uorescence in nontransgenic   Ets1     /     Th1 effectors activated 
in parallel. Data are from two mice of each genotype analyzed in two 
separate experiments. (B) Recruitment of Ets1 protein to the   Runx3   gene 
in vivo was assessed by ChIP assays on Th1 effector T cells. Bar graphs 
represent fold-enrichment of segments C, D, E, and G from the   Runx3  
gene (  Fig. S8   for location) in anti-Ets1 immunoprecipitates, expressed as 
indicated in Materials and methods. Horizontal bars depict background 
enrichment as detected in the ROR     and TLR9 genes. The top and bottom 
graphs represent two distinct experiments, each from a separate chroma-
tin  preparation.   2696 Ets1 and CD8 lineage differentiation   | Zamisch et al. 
  The possibility that the intracellular calcium concentration, 
and thereby TCR signals, aff  ects Ets1 activation of   Runx3   ex-
pression raises a provocative correlate with the biology of 
CD4-CD8 lineage choice. Current models propose that TCR 
signals are of longer duration in MHC II– than in MHC I–sig-
naled thymocytes, and thereby promote CD4 over CD8 lin-
eage choice (  Singer and Bosselut, 2004  ). In this perspective, it 
is conceivable, although at present speculative, that persistent 
TCR signals in MHC II–restricted thymocytes would result in 
sustained Ets1 phosphorylation, which in turn would minimize 
Ets1 recruitment to the   Runx3   gene and contribute to limit its 
expression. It is likely that multiple mechanisms contribute to 
match lineage choice to MHC specifi  city in the thymus and 
aff  ect   Runx3   expression (  Singer et al., 2008  ), and further work 
will be needed to evaluate the potential role of Ets1 phosphory-
lation in this process. However, mice genetically engineered 
to express only Ets1 molecules lacking exon 7–encoded se-
quences (and therefore not subject to phosphorylation-induced 
inhibition of DNA binding) have a slightly increased frequency 
of CD8 SP thymocytes (  Higuchi et al., 2007  ), consistent with 
the possibility that increased Ets1 DNA binding would favor 
  Runx3   expression and CD8 cell diff  erentiation. 
  Because Runx activity also contributes to repress the CD4-
committing factor Thpok (  Setoguchi et al., 2008  ), it could be 
envisioned that impaired   Runx3   expression as a result of   Ets1   
disruption would cause MHC I–restricted thymocytes to up-
regulate Thpok and therefore to fail CD8 diff  erentiation or to 
be redirected into the CD4 lineage. However, we did not de-
tect Thpok expression in Ets1      /      MHC I–restricted thymo-
cytes, possibly because Runx1 expression in these cells was 
suffi   cient to prevent their up-regulation of Thpok. 
  The heterogeneity of CD4 and Runx3 expression in 
  Ets1        /      MHC I–restricted thymocytes is reminiscent of the 
variegated CD4 expression by   Runx3  -defi  cient CD8 lineage 
cells, which include maturelike DP thymocytes similar to those 
found in   Ets1        /      mice (  Taniuchi et al., 2002a  ;   Woolf et al., 
2003  ). Expression of   Cd4   and   Cd8   genes is also subject to var-
iegation as a result of mutations of the   Cd4   silencer and of   Cd8   
enhancers, respectively (  Kioussis and Ellmeier, 2002  ;   Taniuchi 
et al., 2004  ). “Pronase stripping” analyses suggest a second 
source for the heterogeneity of   Cd4   expression by   Ets1        /      
CD8 lineage cells, namely that   Ets1   disruption delays, rather 
than prevents,   Cd4   silencing (and presumably   Runx3   up-regu-
lation). It is also important to note that the pleiotropic eff  ects 
of   Ets1   disruption, including on TCR     allelic exclusion 
(  Eyquem et al., 2004  ), may indirectly aff  ect the sequence of 
developmental events that normally characterize positive selec-
tion. It is possible that such changes feedback on lineage-specifi  c 
gene expression programs, and, combined with environmental 
constraints unique to each cell, contribute to the hetero-
geneous   Runx3   and   Cd4   expression of   Ets1        /      thymocytes. 
  In summary, the present study demonstrates the transcrip-
tion factor Ets1 is required for the proper cessation of   Cd4   
expression during the intrathymic development of MHC 
I–restricted CD8 lineage cells, and that it acts at least in part 
by promoting the expression of the   Cd4   repressor   Runx3  . 
et al., 2000  ;   Gu et al., 2000  ). Specifi  cally, a putative Ets1 
motif exists between the two Runx binding sites of the si-
lencer (  Sawada et al., 1994  ;   Taniuchi et al., 2002a  ) raising the 
possibility that Ets1 would bind the silencer and cooperate 
with Runx3 to promote   Cd4   silencing. Although we did not 
observe any cooperative eff  ect of Ets1 and Runx3 on silencer 
activity in cotransfection experiments (unpublished data), the 
present study does not directly evaluate this hypothesis. 
However, the fact that enforced Runx3 expression in   Ets1        /      
thymocytes results in effi   cient   Cd4   silencing indicates that 
this function of Runx3 is not strictly Ets1-dependent. 
  Potential targets of Ets1, including CD5 or TCR genes, 
have been identifi  ed in vitro (  Ho et al., 1990  ;   Prosser et al., 
1992  ;   Tung et al., 2001  ;   Arman et al., 2004  ) and in a large-
scale ChIP study of Ets1 binding in the Jurkat human T cell 
line (  Hollenhorst et al., 2007  ). However, only a few genes, in-
cluding IFN-     (  Grenningloh et al., 2005  ) and   Runx3   (this 
study) have been shown to both recruit and require Ets1 for their 
expression in vivo. We detected direct binding of Ets1 to the 
  Runx3   locus in Th1 eff  ectors, that, similar to CD8-diff  erenti-
ating thymocytes, express both Ets1 and Runx3 (  Grenningloh 
et al., 2005  ;   Djuretic et al., 2007  ;   Naoe et al., 2007  ) and in 
which Ets1 similarly promotes   Runx3   expression. These obser-
vations support the possibility that Ets1 directly promotes 
  Runx3   expression by binding the   Runx3   gene. While the two 
areas of Ets1 binding we identifi  ed on   Runx3   are more than 
30 kb apart on the sequence, it is possible that they are in close 
vicinity in the three-dimensional structure of the nucleus. That 
such an architecture is important for Ets1-mediated activation 
of   Runx3   expression would be consistent with our observation 
that neither the distal promoter region nor the intronic Ets1 
motif, when analyzed in isolation, respond to Ets1 in cotrans-
fection experiments in T cell lines (unpublished data). 
  That Ets1 promotes   Runx3   expression is consistent with 
the expression pattern of these two genes.   Ets1   and   Runx3   are 
coexpressed at multiple stages of T cell diff  erentiation, includ-
ing in early DN thymocytes, in CD8 lineage cells, in Th1 ef-
fectors, and in NK T cells (  Anderson et al., 1999  ;   Taniuchi 
et al., 2002a  ;   Woolf et al., 2003  ). However, although expres-
sion of   Runx3   in the T cell lineage is stage specifi  c, expression 
of   Ets1   is more promiscuous and is not restricted to CD8 lin-
eage cells during positive selection. This brings two possibilities 
as to the function of Ets1 in   Runx3   expression. First, it is possi-
ble that Ets1 serves as a “permissive” or priming factor, that 
makes thymocytes competent to express   Runx3   but would not 
serve to convert extra-cellular clues into   Runx3   expression. 
Second, intrathymic signals could trigger post-translational 
modifi  cations that constrain Ets1 activity, thereby making Ets1 
a “signal-sensor” that contributes to adjust   Runx3   levels in re-
sponse to environmental cues. Ets1 DNA binding in vitro is 
inhibited by the calcium-induced phosphorylation of serines 
encoded within its exon 7 (  Pognonec et al., 1990  ;   Pufall et al., 
2005  ). Although these modifi  cations do not appear essential for 
Ets1 functions during Th1 eff  ector diff  erentiation (  Grenningloh 
et al., 2008  ), there is genetic evidence that they aff  ect Ets1 ac-
tivity in thymocytes (  Higuchi et al., 2007  ). JEM VOL. 206, November 23, 2009 
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  Online supplemental material.     Fig. S1 shows thymocyte subsets in 
  Ets1        /      newborn mice. Fig. S2 analyzes T cell selection in TCR transgenic 
  Ets1        /      thymi. Fig. S3 displays the sorting strategy used in the coreceptor 
reexpression assay (  Fig. 5 A  ). Fig. S4 shows the schematic structure and ex-
pression pattern of the   Runx3   tRFP BAC reporter. Fig. S5 shows expression 
of the   Runx3   transgene in thymocyte subsets. Fig. S6 documents that   Ets1   
disruption does not aff  ect expression of the   Runx3   transgene. Fig. S7 shows 
that   Ets1   is not required for   Runx3  -mediated CD4 repression. Fig. S8 dis-
plays the location and sequence of Ets1 binding regions detected by ChIP 
analyses on the   Runx3   gene. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20092024/DC1. 
  We thank M. Satake for the anti-Runx antiserum, Barbara Taylor, and Subhadra 
Banerjee for cell sorting; Susan Garfi  eld for assistance with confocal microscopy; 
Ehydel Castro, Peter Mercado, and Genevieve Sanchez for expert mouse care; 
Al Singer for insightful discussions; and Jon Ashwell, Anne Gégonne, Ranjan Sen, 
and Al Singer for critical reading of the manuscript. 
  This work was supported in part by the Intramural Research Program of the 
National Cancer Institute, Center for Cancer Research, National Institutes of Health 
(NIH), and by NIH grant AI081052. M. Ehlers is a fellow of the Claussen-Simon-
Foundation and supported by the Max-Planck-Institute for Infection Biology, 
Germany. 
  The authors have no confl  icting fi  nancial interests. 
Submitted:   17 September 2009 
Accepted:   20 October 2009 
  REFERENCES 
      Anderson  ,   M.K.  ,   G.     Hernandez-Hoyos  ,   R.A.     Diamond  , and   E.V.   
  Rothenberg  .   1999  .   Precise developmental regulation of Ets family tran-
scription factors during specifi  cation and commitment to the T cell lin-
eage.       Development      .     126  :  3131  –  3148  .   
      Arman  ,   M.  ,   J.     Calvo  ,   M.E.     Trojanowska  ,   P.N.     Cockerill  ,   M.     Santana  ,   M.   
  López-Cabrera  ,   J.     Vives  , and   F.     Lozano  .   2004  .   Transcriptional regula-
tion of human CD5: important role of Ets transcription factors in CD5 
expression in T cells.       J. Immunol.       172  :  7519  –  7529  .   
      Barnden  ,   M.J.  ,   J.     Allison  ,   W.R.     Heath  , and   F.R.     Carbone  .   1998  .   Defective 
TCR expression in transgenic mice constructed using cDNA-based 
alpha- and beta-chain genes under the control of heterologous regula-
tory elements.       Immunol. Cell Biol.       76  :  34  –  40  .   doi:10.1046/j.1440-1711
.1998.00709.x     
      Barton  ,   K.  , and   G.     Nucifora  .   2000  .   AML1 haploinsuffi   ciency, gene dosage, and 
the predisposition to acute leukemia.       Bioessays      .     22  :  214  –  218  .   doi:10.1002/
(SICI)1521-1878(200003)22:3<214::AID-BIES2>3.0.CO;2-I     
      Barton  ,   K.  ,   N.     Muthusamy  ,   C.     Fischer  ,   C.N.     Ting  ,   T.L.     Walunas  ,   L.L.   
  Lanier  , and   J.M.     Leiden  .   1998  .   The Ets-1 transcription factor is required 
for the development of natural killer cells in mice.       Immunity      .     9  :  555  –  563  . 
  doi:10.1016/S1074-7613(00)80638-X     
      Bories  ,   J.C.  ,   D.M.     Willerford  ,   D.     Grévin  ,   L.     Davidson  ,   A.     Camus  ,   P.   
  Martin  ,   D.     Stéhelin  , and   F.W.     Alt  .   1995  .   Increased T-cell apoptosis 
and terminal B-cell diff  erentiation induced by inactivation of the Ets-1 
proto-oncogene.       Nature      .     377  :  635  –  638  .   doi:10.1038/377635a0     
      Bosselut  ,   R.     2004  .   CD4/CD8-lineage diff  erentiation in the thymus: from 
nuclear eff  ectors to membrane signals.       Nat. Rev. Immunol.       4  :  529  –  540  . 
  doi:10.1038/nri1392     
      Brugnera  ,   E.  ,   A.     Bhandoola  ,   R.     Cibotti  ,   Q.     Yu  ,   T.I.     Guinter  ,   Y.     Yamashita  , 
  S.O.     Sharrow  , and   A.     Singer  .   2000  .   Coreceptor reversal in the thy-
mus: signaled CD4+8+ thymocytes initially terminate CD8 transcrip-
tion even when diff  erentiating into CD8+ T cells.       Immunity      .     13  :  59  –  71  . 
  doi:10.1016/S1074-7613(00)00008-X     
      Clements  ,   J.L.  ,   S.A.     John  , and   L.A.     Garrett-Sinha  .   2006  .   Impaired generation 
of CD8+ thymocytes in Ets-1-defi  cient mice.       J. Immunol.       177  :  905  –  912  .   
      Cruz-Guilloty  ,   F.  ,   M.E.     Pipkin  ,   I.M.     Djuretic  ,   D.     Levanon  ,   J.     Lotem  ,   M.G.   
  Lichtenheld  ,   Y.     Groner  , and   A.     Rao  .   2009  .   Runx3 and T-box proteins 
cooperate to establish the transcriptional program of eff  ector CTLs.   
    J. Exp. Med.       206  :  51  –  59  .   doi:10.1084/jem.20081242     
  MATERIALS AND METHODS 
  Mice.     Wild-type C57BL/6 (B6) mice were obtained from the National 
Cancer Institute (NCI) animal production facility. Mice carrying a disrupted 
  Ets1   locus (  Barton et al., 1998  ) were maintained heterozygous and inter-
crossed to obtain   Ets1        /      mice. Mice carrying the P14 TCR transgene 
(  Pircher et al., 1989  ; originally obtained from Taconic) or the OT-II TCR 
transgene (  Barnden et al., 1998  ; originally obtained from Jax), and mice car-
rying a   Runx3   transgene (  Grueter et al., 2005  ) were intercrossed with   Ets1    +/      
animals to generate   Ets1        /      mice with the desired transgene combination. 
Mice were housed in a specifi  c pathogen–free facility and were analyzed be-
tween 6 and 12 wk of age, unless otherwise indicated. The BAC reporter 
transgene for   Runx3   expression was prepared as previously described (  Wang 
et al., 2008a  ) by inserting a tRFP cDNA (tdTomato, a gift from R. Tsien, 
University of California, San Diego, La Jolla, CA;   Shaner et al., 2005  ), using 
recombineering technology (http://recombineering.ncifcrf.gov/), and mi-
croinjected into C57BL/6 fertilized oocytes. Resulting animals (I5-founder–
derived line) were backcrossed to   Ets1        /      mice. Animal procedures were 
approved by the NCI Animal Care and Use Committee. 
  Cell preparation, staining, and analyses of gene expression.     Single-
cell suspensions of thymocytes and splenocytes were prepared and stained as 
described previously (  Liu et al., 2003  ). Flow cytometry data were acquired 
either on a two-laser FACSCalibur or on an LSR-II cytometer (both from 
BD) using the software and confi  guration provided by the manufacturer. 
Data were analyzed with FlowJo Software (Tree Star, Inc.). Dead cells were 
excluded from analyses on the basis of Forward Light Scatter and either pro-
pidium iodide, DAPI, or 7-AAD gating. Cell sorting was performed on a 
FACSVantage SE (BD). RNA was extracted from sorted cells with TRIzol 
(Invitrogen), reverse-transcribed from oligo-dT primers, and analyzed by 
quantitative real time PCR as previously described (  Jenkinson et al., 2007  ), 
using an ABI PRISM 7900HT sequence detection system (Applied Biosys-
tems) and previously published primer and probe sets (  Jenkinson et al., 
2007  ). Gene expression values are normalized to     -actin in the same sample. 
Expression of Runx proteins was analyzed by immunoblotting of whole-cell 
lysates with an antibody that recognizes Runx1 and Runx3, a generous gift 
of M. Satake, Tohoku University, Sendai, Japan (  Sato et al., 2005  ); expres-
sion of     -actin on the same membrane was assessed as a loading control, and 
quantifi  ed using the Odyssey system (Li-Cor) where indicated. Analyses of 
CD4 and CD8 reexpression after pronase stripping were conducted as previ-
ously described (  Brugnera et al., 2000  ). 
  Immunohistology.     OCT-embedded frozen tissue sections were air-
dried 15 min before acetone fi  xation. For costaining, sections were incu-
bated simultaneously with optimal dilutions of polyclonal anti-mouse 
keratin 14 (Covance Research), FITC anti–mouse CD8 (clone 53–6.7), 
and anti–mouse CD4 (clone H129-19; BD). Immunoreactivity to CD4 
was enhanced by tyramide amplifi  cation (PerkinElmer). Controls included 
slides incubated with normal rabbit IgG or isotype-matched rat IgG. 
Microscopic analysis was performed with a LSM 510 confocal microscope 
(Carl Zeiss, Inc.). 
  ChIP assays.     ChIP was performed from   Ets1    +/+   Th1 eff  ector CD4  +   cells 
as previously described (  Grenningloh et al., 2005  ). A detailed protocol is 
available upon request. The following antibodies were used: rabbit anti-Ets1 
(C-20) and control rabbit IgG (both from Santa Cruz Biotechnology, Inc.). 
Isolated DNA fragments were amplifi   ed by quantitative PCR (Mx300P, 
Stratagene) using the following primers: Segment C (F, 5    -GTTGACTGGT-
GGGAATAAAG-3    ; R, 5    -AGGGTTTGGCACATACTG-3    ), segment D 
(F, 5    -AACACCCTAAGAGCATCAAA-3    ; R, 5    -TTTATGGGAGTT-
GGGATTTA-3    ), segments E (F, 5    -ATCCACAAACAGAAAGCCTA-3    ; 
R, 5    -TGTCAACCCAATCTCACAT-3    ), and segment G (F, 5    -TAACC-
GGTAACTGGGATG-3    ; R, 5    -CGCTGAGGTTGAGAGTGT-3    ). For 
each target segment, fold enrichment was defi  ned as the ratio of the target in 
the anti-Ets1 immunoprecipitates relative to the control IgG immunoprecipi-
tate, calculated as 2  ([anti-Ets1     cycle     number]      [control     cycle     number])  . 2698 Ets1 and CD8 lineage differentiation   | Zamisch et al. 
      Jenkinson  ,   S.R.  ,   A.M.     Intlekofer  ,   G.     Sun  ,   L.     Feigenbaum  ,   S.L.     Reiner  , and 
  R.     Bosselut  .   2007  .   Expression of the transcription factor cKrox in pe-
ripheral CD8 T cells reveals substantial postthymic plasticity in CD4-
CD8 lineage diff  erentiation.      J. Exp. Med.      204  :  267  –  272  .  doi:10.1084/jem
.20061982     
      Kim  ,  W.Y.  ,  M.    Sieweke  ,  E.    Ogawa  ,  H.J.    Wee  ,  U.    Englmeier  ,  T.    Graf  , and  Y.   
  Ito  .   1999  .   Mutual activation of Ets-1 and AML1 DNA binding by direct 
interaction of their autoinhibitory domains.       EMBO J.       18  :  1609  –  1620  . 
  doi:10.1093/emboj/18.6.1609     
      Kioussis  ,  D.  , and  W.    Ellmeier  .  2002  .  Chromatin and CD4, CD8A and CD8B 
gene expression during thymic diff  erentiation.       Nat. Rev. Immunol.       2  :
  909  –  919  .   doi:10.1038/nri952     
      Kishimoto  ,  H.  , and  J.    Sprent  .  1999  .  Several diff  erent cell surface molecules con-
trol negative selection of medullary thymocytes.       J. Exp. Med.       190  :  65  –  73  .   
doi:10.1084/jem.190.1.65     
      Klug  ,   D.B.  ,   C.     Carter  ,   E.     Crouch  ,   D.     Roop  ,   C.J.     Conti  , and   E.R.     Richie  . 
  1998  .   Interdependence of cortical thymic epithelial cell diff  erentiation 
and T-lineage commitment.     Proc. Natl. Acad. Sci. USA      .    95  :  11822  –  11827  .   
doi:10.1073/pnas.95.20.11822     
      Kohu  ,   K.  ,   T.     Sato  ,   S.     Ohno  ,   K.     Hayashi  ,   R.     Uchino  ,   N.     Abe  ,   M.     Nakazato  , 
  N.     Yoshida  ,   T.     Kikuchi  ,   Y.     Iwakura  ,   et al  .   2005  .   Overexpression of the 
Runx3 transcription factor increases the proportion of mature thymo-
cytes of the CD8 single-positive lineage.       J. Immunol.       174  :  2627  –  2636  .   
      Liu  ,   X.  , and   R.     Bosselut  .   2004  .   Duration of TCR signaling controls CD4-CD8 
lineage diff  erentiation in vivo.       Nat. Immunol.       5  :  280  –  288  .   doi:10.1038/
ni1040     
      Liu  ,   X.  ,   A.     Adams  ,   K.F.     Wildt  ,   B.     Aronow  ,   L.     Feigenbaum  , and   R.   
  Bosselut  .   2003  .   Restricting Zap70 expression to CD4+CD8+ thymo-
cytes reveals a T cell receptor-dependent proofreading mechanism con-
trolling the completion of positive selection.       J. Exp. Med.       197  :  363  –  373  . 
  doi:10.1084/jem.20021698     
      Muroi  ,   S.  ,   Y.     Naoe  ,   C.     Miyamoto  ,   K.     Akiyama  ,   T.     Ikawa  ,   K.     Masuda  , 
  H.     Kawamoto  , and   I.     Taniuchi  .   2008  .   Cascading suppression of tran-
scriptional silencers by ThPOK seals helper T cell fate.       Nat. Immunol.     
  9  :  1113  –  1121  .   doi:10.1038/ni.1650     
      Muthusamy  ,   N.  ,   K.     Barton  , and   J.M.     Leiden  .   1995  .   Defective activation and 
survival of T cells lacking the Ets-1 transcription factor.       Nature      .     377  : 
639  –  642  .   doi:10.1038/377639a0     
      Naoe  ,   Y.  ,   R.     Setoguchi  ,   K.     Akiyama  ,   S.     Muroi  ,   M.     Kuroda  ,   F.     Hatam  , 
  D.R.     Littman  , and   I.     Taniuchi  .   2007  .   Repression of interleukin-4 in 
T helper type 1 cells by Runx/Cbf     binding to the Il4 silencer.       J. Exp. 
Med.       204  :  1749  –  1755  .   doi:10.1084/jem.20062456     
      Pai  ,   S.Y.  ,   M.L.     Truitt  ,   C.N.     Ting  ,   J.M.     Leiden  ,   L.H.     Glimcher  , and   I.C.     Ho  . 
  2003  .  Critical roles for transcription factor GATA-3 in thymocyte devel-
opment.       Immunity      .     19  :  863  –  875  .   doi:10.1016/S1074-7613(03)00328-5     
      Pircher  ,   H.  ,   K.     Bürki  ,   R.     Lang  ,   H.     Hengartner  , and   R.M.     Zinkernagel  . 
  1989  .   Tolerance induction in double specifi  c T-cell receptor transgenic 
mice varies with antigen.       Nature      .     342  :  559  –  561  .   doi:10.1038/342559a0     
      Pognonec  ,   P.  ,   K.E.     Boulukos  ,   R.     Bosselut  ,   C.     Boyer  ,   A.M.     Schmitt-
Verhulst  , and   J.     Ghysdael  .   1990  .   Identifi  cation of a Ets1 variant protein 
unaff  ected in its chromatin and in vitro DNA binding capacities by 
T cell antigen receptor triggering and intracellular calcium rises.       Oncogene      .   
  5  :  603  –  610  .   
      Prosser  ,   H.M.  ,   D.     Wotton  ,   A.     Gegonne  ,   J.     Ghysdael  ,   S.     Wang  ,   N.A.     Speck  , 
and   M.J.     Owen  .   1992  .   A phorbol ester response element within the hu-
man T-cell receptor beta-chain enhancer.       Proc. Natl. Acad. Sci. USA      .     89  : 
9934  –  9938  .   doi:10.1073/pnas.89.20.9934     
      Pufall  ,   M.A.  ,   G.M.     Lee  ,   M.L.     Nelson  ,   H.S.     Kang  ,   A.     Velyvis  ,   L.E.     Kay  ,   L.P.   
  McIntosh  , and   B.J.     Graves  .   2005  .   Variable control of Ets-1 DNA bind-
ing by multiple phosphates in an unstructured region.       Science      .     309  :  142  –
  145  .   doi:10.1126/science.1111915     
      Sato  ,   T.  ,   S.     Ohno  ,   T.     Hayashi  ,   C.     Sato  ,   K.     Kohu  ,   M.     Satake  , and   S.     Habu  . 
  2005  .   Dual functions of Runx proteins for reactivating CD8 and silenc-
ing CD4 at the commitment process into CD8 thymocytes.       Immunity      .   
  22  :  317  –  328  .   doi:10.1016/j.immuni.2005.01.012     
      Sawada  ,  S.  ,  J.D.    Scarborough  ,  N.    Killeen  , and  D.R.    Littman  .  1994  .  A lineage-
specifi  c transcriptional silencer regulates CD4 gene expression during 
T lymphocyte development.       Cell      .     77  :  917  –  929  .   doi:10.1016/
0092-8674(94)90140-6     
      Djuretic  ,   I.M.  ,   D.     Levanon  ,   V.     Negreanu  ,   Y.     Groner  ,   A.     Rao  , and   K.M.   
  Ansel  .  2007  .  Transcription factors T-bet and Runx3 cooperate to activate 
Ifng and silence Il4 in T helper type 1 cells.       Nat. Immunol.       8  :  145  –  153  .   
doi:10.1038/ni1424     
      Egawa  ,   T.  , and   D.R.     Littman  .   2008  .   ThPOK acts late in specifi  cation of the 
helper T cell lineage and suppresses Runx-mediated commitment to the 
cytotoxic T cell lineage.       Nat. Immunol.       9  :  1131  –  1139  .   doi:10.1038/ni.1652     
      Egawa  ,   T.  ,   R.E.     Tillman  ,   Y.     Naoe  ,   I.     Taniuchi  , and   D.R.     Littman  .   2007  . 
  The role of the Runx transcription factors in thymocyte diff  erentia-
tion and in homeostasis of naive T cells.       J. Exp. Med.       204  :  1945  –  1957  . 
  doi:10.1084/jem.20070133     
      Ehlers  ,   M.  ,   K.     Laule-Kilian  ,   M.     Petter  ,   C.J.     Aldrian  ,   B.     Grueter  ,   A.   
  Würch  ,   N.     Yoshida  ,   T.     Watanabe  ,   M.     Satake  , and   V.     Steimle  .   2003  . 
  Morpholino antisense oligonucleotide-mediated gene knockdown dur-
ing thymocyte development reveals role for Runx3 transcription factor 
in CD4 silencing during development of CD4-/CD8+ thymocytes.   
    J. Immunol.       171  :  3594  –  3604  .   
      Erman  ,   B.  ,   M.     Cortes  ,   B.S.     Nikolajczyk  ,   N.A.     Speck  , and   R.     Sen  .   1998  . 
  ETS-core binding factor: a common composite motif in antigen recep-
tor gene enhancers.       Mol. Cell. Biol.       18  :  1322  –  1330  .   
      Eyquem  ,   S.  ,   K.     Chemin  ,   M.     Fasseu  , and   J.C.     Bories  .   2004  .   The Ets-1 tran-
scription factor is required for complete pre-T cell receptor function 
and allelic exclusion at the T cell receptor beta locus.       Proc. Natl. Acad. 
Sci. USA      .     101  :  15712  –  15717  .   doi:10.1073/pnas.0405546101     
      Fowlkes  ,   B.J.  , and   D.M.     Pardoll  .   1989  .   Molecular and cellular events of 
T cell development.       Adv. Immunol.       44  :  207  –  264  .   doi:10.1016/S0065-
2776(08)60643-4     
      Goetz  ,   T.L.  ,   T.L.     Gu  ,   N.A.     Speck  , and   B.J.     Graves  .   2000  .   Auto-inhibition of 
Ets-1 is counteracted by DNA binding cooperativity with core-binding 
factor alpha2.       Mol. Cell. Biol.       20  :  81  –  90  .   doi:10.1128/MCB.20.1.81-
90.2000     
      Grenningloh  ,   R.  ,   B.Y.     Kang  , and   I.C.     Ho  .   2005  .   Ets-1, a functional cofactor 
of T-bet, is essential for Th1 infl  ammatory responses.       J. Exp. Med.       201  : 
615  –  626  .   doi:10.1084/jem.20041330     
      Grenningloh  ,   R.  ,   S.C.     Miaw  ,   J.     Moisan  ,   B.J.     Graves  , and   I.C.     Ho  .   2008  . 
  Role of Ets-1 phosphorylation in the eff  ector function of Th cells.       Eur. 
J. Immunol.       38  :  1700  –  1705  .   doi:10.1002/eji.200738112     
      Grueter  ,   B.  ,   M.     Petter  ,   T.     Egawa  ,   K.     Laule-Kilian  ,   C.J.     Aldrian  ,   A.     Wuerch  , 
  Y.     Ludwig  ,   H.     Fukuyama  ,   H.     Wardemann  ,   R.     Waldschuetz  ,   et al  .   2005  . 
  Runx3 regulates integrin alpha E/CD103 and CD4 expression during 
development of CD4-/CD8+ T cells.       J. Immunol.       175  :  1694  –  1705  .   
      Gu  ,   T.L.  ,   T.L.     Goetz  ,   B.J.     Graves  , and   N.A.     Speck  .   2000  .   Auto-inhibi-
tion and partner proteins, core-binding factor beta (CBFbeta) and Ets-1, 
modulate DNA binding by CBFalpha2 (AML1).       Mol. Cell. Biol.       20  :  91  –
  103  .   doi:10.1128/MCB.20.1.91-103.2000     
      He  ,   X.  ,   X.     He  ,   V.P.     Dave  ,   Y.     Zhang  ,   X.     Hua  ,   E.     Nicolas  ,   W.     Xu  ,   B.A.     Roe  , 
and   D.J.     Kappes  .   2005  .   The zinc fi  nger transcription factor Th-POK 
regulates CD4 versus CD8 T-cell lineage commitment.       Nature      .     433  : 
826  –  833  .   doi:10.1038/nature03338     
      Hernández-Hoyos  ,   G.  ,   M.K.     Anderson  ,   C.     Wang  ,   E.V.     Rothenberg  , and   J.   
  Alberola-Ila  .  2003  .  GATA-3 expression is controlled by TCR signals and 
regulates CD4/CD8 diff  erentiation.       Immunity      .     19  :  83  –  94  .   doi:10.1016/
S1074-7613(03)00176-6     
      Higuchi  ,   T.  ,   F.O.     Bartel  ,   M.     Masuya  ,   T.     Deguchi  ,   K.W.     Henderson  , 
  R.     Li  ,   R.C.     Muise-Helmericks  ,   M.J.     Kern  ,   D.K.     Watson  , and   D.D.   
  Spyropoulos  .   2007  .   Thymomegaly, microsplenia, and defective homeo-
static proliferation of peripheral lymphocytes in p51-Ets1 isoform-specifi  c 
null mice.       Mol. Cell. Biol.       27  :  3353  –  3366  .   doi:10.1128/MCB.01871-06     
      Ho  ,  I.C.  ,  N.K.    Bhat  ,  L.R.    Gottschalk  ,  T.    Lindsten  ,  C.B.    Thompson  ,  T.S.    Papas  , 
and   J.M.     Leiden  .   1990  .   Sequence-specifi  c binding of human Ets-1 to the 
T cell receptor alpha gene enhancer.       Science      .     250  :  814  –  818  .   doi:10.1126/
science.2237431     
      Hogquist  ,   K.A.  ,   S.C.     Jameson  ,   W.R.     Heath  ,   J.L.     Howard  ,   M.J.     Bevan  , and 
  F.R.     Carbone  .   1994  .   T cell receptor antagonist peptides induce positive 
selection.       Cell      .     76  :  17  –  27  .   doi:10.1016/0092-8674(94)90169-4     
      Hollenhorst  ,  P.C.  ,  A.A.    Shah  ,  C.    Hopkins  , and  B.J.    Graves  .  2007  .  Genome-wide 
analyses reveal properties of redundant and specifi  c promoter occupancy 
within the ETS gene family.     Genes Dev.      21  :  1882  –  1894  .  doi:10.1101/gad
.1561707     JEM VOL. 206, November 23, 2009 
Article
2699
      Setoguchi  ,   R.  ,   M.     Tachibana  ,   Y.     Naoe  ,   S.     Muroi  ,   K.     Akiyama  ,   C.     Tezuka  , 
  T.     Okuda  , and   I.     Taniuchi  .   2008  .   Repression of the transcription factor 
Th-POK by Runx complexes in cytotoxic T cell development.       Science      .   
  319  :  822  –  825  .   doi:10.1126/science.1151844     
      Shaner  ,   N.C.  ,   P.A.     Steinbach  , and   R.Y.     Tsien  .   2005  .   A guide to choos-
ing fl  uorescent  proteins.       Nat. Methods      .     2  :  905  –  909  .   doi:10.1038/
nmeth819     
      Sharrocks  ,   A.D.     2001  .   The ETS-domain transcription factor family.       Nat. 
Rev. Mol. Cell Biol.       2  :  827  –  837  .   doi:10.1038/35099076     
      Singer  ,  A.  , and  R.    Bosselut  .  2004  .  CD4/CD8 coreceptors in thymocyte de-
velopment, selection, and lineage commitment: analysis of the CD4/CD8 
lineage decision.       Adv. Immunol.       83  :  91  –  131  .   doi:10.1016/S0065-2776(04)
83003-7     
      Singer  ,  A.  ,  S.    Adoro  , and  J.H.    Park  .  2008  .  Lineage fate and intense debate: myths, 
models and mechanisms of CD4- versus CD8-lineage choice.       Nat. Rev. 
Immunol.       8  :  788  –  801  .   doi:10.1038/nri2416     
      Starr  ,   T.K.  ,   S.C.     Jameson  , and   K.A.     Hogquist  .   2003  .   Positive and negative se-
lection of T cells.       Annu. Rev. Immunol.       21  :  139  –  176  .   doi:10.1146/annurev
.immunol.21.120601.141107     
      Sun  ,   G.  ,   X.     Liu  ,   P.     Mercado  ,   S.R.     Jenkinson  ,   M.     Kypriotou  ,   L.     Feigenbaum  , 
  P.     Galéra  , and   R.     Bosselut  .   2005  .   The zinc fi  nger protein cKrox directs 
CD4 lineage diff  erentiation during intrathymic T cell positive selection.   
    Nat. Immunol.       6  :  373  –  381  .   doi:10.1038/ni1183     
      Suzuki  ,   H.  ,   J.A.     Punt  ,   L.G.     Granger  , and   A.     Singer  .   1995  .   Asymmetric sig-
naling requirements for thymocyte commitment to the CD4+ versus 
CD8+ T cell lineages: a new perspective on thymic commitment and 
selection.       Immunity      .     2  :  413  –  425  .   doi:10.1016/1074-7613(95)90149-3     
      Swat  ,   W.  ,   M.     Dessing  ,   H.     von Boehmer  , and   P.     Kisielow  .   1993  .   CD69 ex-
pression during selection and maturation of CD4+8+ thymocytes.       Eur. 
J. Immunol.       23  :  739  –  746  .   doi:10.1002/eji.1830230326     
      Takahama  ,   Y.     2006  .   Journey through the thymus: stromal guides for T-cell 
development and selection.     Nat. Rev. Immunol.      6  :  127  –  135  .  doi:10.1038/
nri1781     
      Taniuchi  ,   I.  ,   M.     Osato  ,   T.     Egawa  ,   M.J.     Sunshine  ,   S.C.     Bae  ,   T.     Komori  , 
  Y.     Ito  , and   D.R.     Littman  .   2002a  .   Diff  erential requirements for Runx 
proteins in CD4 repression and epigenetic silencing during T lympho-
cyte development.       Cell      .     111  :  621  –  633  .   doi:10.1016/S0092-8674(02)
01111-X     
      Taniuchi  ,   I.  ,   M.J.     Sunshine  ,   R.     Festenstein  , and   D.R.     Littman  .   2002b  . 
  Evidence for distinct CD4 silencer functions at diff  erent stages of thy-
mocyte diff  erentiation.       Mol. Cell      .     10  :  1083  –  1096  .   
      Taniuchi  ,   I.  ,   W.     Ellmeier  , and   D.R.     Littman  .   2004  .   The CD4/CD8 lineage 
choice: new insights into epigenetic regulation during T cell develop-
ment.       Adv. Immunol.       83  :  55  –  89  .   doi:10.1016/S0065-2776(04)83002-5     
      Telfer  ,   J.C.  ,   E.E.     Hedblom  ,   M.K.     Anderson  ,   M.N.     Laurent  , and   E.V.   
  Rothenberg  .   2004  .   Localization of the domains in Runx transcription 
factors required for the repression of CD4 in thymocytes.       J. Immunol.     
  172  :  4359  –  4370  .   
      Tung  ,   J.W.  ,   S.S.     Kunnavatana  ,   L.A.     Herzenberg  , and   L.A.     Herzenberg  . 
  2001  .   The regulation of CD5 expression in murine T cells.       BMC Mol. 
Biol.       2  :  5  .   doi:10.1186/1471-2199-2-5     
      Verger  ,   A.  , and   M.     Duterque-Coquillaud  .   2002  .   When Ets transcription fac-
tors meet their partners.       Bioessays      .     24  :  362  –  370  .   doi:10.1002/bies.10068     
      Wang  ,   L.  , and   R.     Bosselut  .   2009  .   CD4-CD8 lineage diff  erentiation: Thpok-
ing into the nucleus.     J. Immunol.      183  :  2903  –  2910  .  doi:10.4049/jimmunol
.0901041     
      Wang  ,   L.  ,   K.F.     Wildt  ,   J.     Zhu  ,   X.     Zhang  ,   L.     Feigenbaum  ,   L.     Tessarollo  ,   W.E.   
  Paul  ,   B.J.     Fowlkes  , and   R.     Bosselut  .   2008a  .   Distinct functions for the tran-
scription factors GATA-3 and ThPOK during intrathymic diff  erentiation 
of CD4(+) T cells.       Nat. Immunol.       9  :  1122  –  1130  .   doi:10.1038/ni.1647     
      Wang  ,  L.  ,  K.F.    Wildt  ,  E.    Castro  ,  Y.    Xiong  ,  L.    Feigenbaum  ,  L.    Tessarollo  , and 
  R.     Bosselut  .   2008b  .   The zinc fi  nger transcription factor Zbtb7b represses 
CD8-lineage gene expression in peripheral CD4+ T cells.       Immunity      .    
29  :  876  –  887  .   doi:10.1016/j.immuni.2008.09.019     
      Wildt  ,   K.F.  ,   G.     Sun  ,   B.     Grueter  ,   M.     Fischer  ,   M.     Zamisch  ,   M.     Ehlers  , and   R.   
  Bosselut  .   2007  .   The transcription factor Zbtb7b promotes CD4 expres-
sion by antagonizing Runx-mediated activation of the CD4 silencer.   
    J. Immunol.       179  :  4405  –  4414  .   
      Woolf  ,  E.  ,  C.    Xiao  ,  O.    Fainaru  ,  J.    Lotem  ,  D.    Rosen  ,  V.    Negreanu  ,  Y.    Bernstein  , 
  D.     Goldenberg  ,   O.     Brenner  ,   G.     Berke  ,   et al  .   2003  .   Runx3 and Runx1 
are required for CD8 T cell development during thymopoiesis.       Proc. Natl. 
Acad. Sci. USA      .     100  :  7731  –  7736  .   doi:10.1073/pnas.1232420100     
      Yu  ,   Q.  ,   B.     Erman  ,   A.     Bhandoola  ,   S.O.     Sharrow  , and   A.     Singer  .   2003  .   In 
vitro evidence that cytokine receptor signals are required for diff  erentia-
tion of double positive thymocytes into functionally mature CD8+ T 
cells.       J. Exp. Med.       197  :  475  –  487  .   doi:10.1084/jem.20021765                         